Enseval Putra Megatrading Tbk (EPMT) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Enseval Putra Megatrading Tbk stock IDR 4,471, price IDR 2,350, upside +90.2%, quality 60 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 1,655 IDR – 2,660 IDR · fair‑value band 2,798 IDR – 6,408 IDR · the 2,350 IDR price screens below the 4,471 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Enseval Putra Megatrading Tbk in your weekly email
Every Wednesday you see whether Enseval Putra Megatrading Tbk is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics, and other trading products in Indonesia.
Show moreShow less
The company operates through three segments: Pharmaceutical, Consumer Products, and Others.
It also trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, consumable products for hemodialysis therapy, pharmaceutical, medical equipment, and food and beverage; prescription and non-prescription medicines; veterinary products; and operates drug stores, health care clinics, and hemodialysis clinic.
In addition, the company provides dental and other equipment; calibration services; distribution and logistics for consumer goods that require cold room temperature handling; transportation and warehousing service using digital platform; information services through web portals and/or digital platforms; healthcare services; end-to-end value added services; and logistic services, including chiller, cool, and ambient rooms, as well as container chiller.
Further, it offers EMOS, a business-to-business (B2B) platform that offers pharmaceuticals and consumer health products; and MOSTRANS, an intelligent logistics platform that connects with shippers, transporters, and receivers.
The company was formerly known as PT Arya Gupta Cempaka and changed its name to PT Enseval Putera Megatrading Tbk. in August 1993. PT Enseval Putera Megatrading Tbk. was founded in 1973 and is headquartered in Jakarta Timur, Indonesia.
PT Enseval Putera Megatrading Tbk. is a subsidiary of PT Kalbe Farma Tbk.
Stock analysis
Enseval Putra Megatrading Tbk (EPMT) currently trades at 2,350 IDR, while our model-based Fair Value estimate is 4,471 IDR, implying the stock looks roughly 47% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 6,380 IDR per share, and 22 of the 26 models we run sit above the 2,350 IDR price.
Bear case: the Dividend Discount group reads lowest at 1,856 IDR, and 4 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: 2,798 IDR (bear) to 6,408 IDR (bull), the price of 2,350 IDR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Enseval Putra Megatrading Tbk reported revenue of 33.0T IDR in FY2025 versus 25.7T IDR in FY2021, a compound +6.4%/yr. Reported net income was 789B IDR in FY2025, compounding −1.8%/yr from FY2021.
Key figures
Market cap 6.4T IDR (≈ $352M) Small · P/E ratio 7.7 · P/S ratio 0.18 · EPS (TTM) 306.00 IDR · Dividend yield 7.3% · Net margin 2.4% · Return on equity 10.5% · Return on assets (EBIT) 9.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 12% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 33% fair-value upside, at 90%, EPMT screens cheaper than that median.
Fair Value models
Bear2,798 IDRFair Value 4,471 IDRBull6,408 IDR
Price 2,350 IDR · Upside +90.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (261.57 IDR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.71/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+6.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.9%
Start year 2020 (pandemic). Over 10 years: +6.6% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+10.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.0%
Dividend (yield on the price)7.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3.0% vs 3.7%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 3%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about +0.5% a year for the price.
Compare Enseval Putra Megatrading Tbk with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 77 stocks
Beats the industry median on 12/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score60 · Top 25%
Fair Value upside+90.2% · Above median
Profitability
Return on equity (12 months)10.5% · Top 25%
Return on assets6.0% · Top 25%
Net margin (12 months)2.4% · Above median
Operating margin (12 months)2.7% · Below median
Growth and dividend
Revenue growth (quarter YoY)18.9% · Top 25%
Dividend yield (12 months)7.3% · Top 25%
Valuation Multiplesvs Medical Distribution median · lower = cheaper
P/E (12 months)7.7× · Cheapest 25%
P/B0.81× · Cheaper than median
P/S (12 months)0.18× · Cheapest 25%
Price / free cash flow (fiscal year)10.6× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Enseval Putra Megatrading Tbk Fair Value". https://www.fairvalue-calculator.com/stock/EPMT
Frequently asked questions
Is Enseval Putra Megatrading Tbk (EPMT) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 4,471 IDR versus a price of 2,350 IDR, about +90% upside (undervalued).
What is the fair value of EPMT?
Our model-based fair value for Enseval Putra Megatrading Tbk is 4,471 IDR (as of Nov 8, 2026), built from audited fundamentals. The current price: 2,350 IDR.
What is the quality score of EPMT?
Enseval Putra Megatrading Tbk has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Enseval Putra Megatrading Tbk (EPMT)?
Our model-based price target is the fair value of 4,471 IDR (as of Nov 8, 2026) from 26 valuation models. Cautious scenario 2,798 IDR, optimistic scenario 6,408 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Enseval Putra Megatrading Tbk stock forecast for 2026?
Our models put fair value at 4,471 IDR, about +90% upside versus a price of 2,350 IDR (undervalued). Cautious scenario 2,798 IDR, optimistic scenario 6,408 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Enseval Putra Megatrading Tbk (EPMT)?
Enseval Putra Megatrading Tbk reported trailing-twelve-month revenue of about 35.2T IDR (latest available figure, as of Nov 8, 2026).
Does Enseval Putra Megatrading Tbk pay a dividend?
Enseval Putra Megatrading Tbk currently shows a dividend yield of 7.34% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Enseval Putra Megatrading Tbk (EPMT)?
Enseval Putra Megatrading Tbk has a dividend yield of 7.3%.
What growth is priced into Enseval Putra Megatrading Tbk (EPMT)?
For today's price to be fair in a discounted-cash-flow model, Enseval Putra Megatrading Tbk would have to grow free cash flow by +3.2 % per year for five years (discount rate 13.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.9 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of EPMT use?
Our models discount Enseval Putra Megatrading Tbk at 13.5 %: a base by market capitalisation (small), country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Enseval Putra Megatrading Tbk that is +3.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.5 %) and the same formula as our fair value.
How much growth has Enseval Putra Megatrading Tbk (EPMT) delivered so far?
Over the past 5 years revenue at Enseval Putra Megatrading Tbk grew +7.9 % a year. The price currently implies free-cash-flow growth of +3.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Enseval Putra Megatrading Tbk (EPMT) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Enseval Putra Megatrading Tbk (+3.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Enseval Putra Megatrading Tbk (EPMT)?
The free-cash-flow yield on the price is 9.42 %: that much free cash flow Enseval Putra Megatrading Tbk produces per unit of market value. When it exceeds the discount rate of our models (13.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Enseval Putra Megatrading Tbk (EPMT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Enseval Putra Megatrading Tbk it is 4,471 IDR per share (as of Nov 8, 2026), against a price of 2,350 IDR. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Enseval Putra Megatrading Tbk stock overvalued or undervalued in 2026?
As of Nov 8, 2026, EPMT trades below its calculated fair value: price 2,350 IDR, fair value 4,471 IDR, a gap of about +90% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of EPMT?
No. The price is what the market pays today (2,350 IDR); the fair value is what the company's own numbers justify (4,471 IDR). For Enseval Putra Megatrading Tbk the two are 2,121 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Enseval Putra Megatrading Tbk worth?
The market values Enseval Putra Megatrading Tbk at about 6.4T IDR (market capitalisation, as of Nov 8, 2026). Per share that is 2,350 IDR; our models calculate a fair value of 4,471 IDR per share.
What do the bullish and bearish scenarios say about EPMT?
Our models span a range for Enseval Putra Megatrading Tbk: cautious scenario 2,798 IDR, base 4,471 IDR, optimistic 6,408 IDR per share (as of Nov 8, 2026, price 2,350 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of EPMT?
Enseval Putra Megatrading Tbk trades at a price-to-earnings ratio of 7.7 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 4,471 IDR is built from several models across several years. Other multiples: P/B 0.8, P/S 0.2, EV/EBITDA 4.3.
How solid is the balance sheet of Enseval Putra Megatrading Tbk (EPMT)?
Balance-sheet figures for Enseval Putra Megatrading Tbk (as of Nov 8, 2026): return on equity 10.5%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is EPMT from its 52-week high?
Enseval Putra Megatrading Tbk trades at 2,350 IDR, about 12% below its 52-week high of 2,660 IDR and 5% above the low of 2,230 IDR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 4,471 IDR is for.
Which stocks are comparable to Enseval Putra Megatrading Tbk?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Enseval Putra Megatrading Tbk stock attractive at the current price?
The data as of Nov 8, 2026: price 2,350 IDR, calculated fair value 4,471 IDR (+90%), Quality Score 60/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of EPMT calculated?
We run Enseval Putra Megatrading Tbk through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 4,471 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Enseval Putra Megatrading Tbk currently trades 47% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Enseval Putra Megatrading Tbk (EPMT)?
The closing price on Nov 6, 2026 was 2,350 IDR. Our model-based fair value is 4,471 IDR, about +90% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Enseval Putra Megatrading Tbk right now?
The price is below even our cautious bear case (2,798 IDR). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (2,798 IDR to 6,408 IDR) leaves room in how you read the outcome.
Where does the earnings growth of Enseval Putra Megatrading Tbk (EPMT) come from?
Earnings per share at Enseval Putra Megatrading Tbk grew +3.6 % a year from 2014 to 2025. Broken into its drivers: revenue per share +6.3 %, EBIT margin −2.8 %, tax rate +0.4 %, residual (interest, one-offs) −0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Enseval Putra Megatrading Tbk
How large is the market capitalisation of Enseval Putra Megatrading Tbk (EPMT)?
The market capitalisation of Enseval Putra Megatrading Tbk is 6.4T IDR (≈ $352M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Enseval Putra Megatrading Tbk (EPMT)?
The price-to-sales ratio of Enseval Putra Megatrading Tbk is 0.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Enseval Putra Megatrading Tbk (EPMT)?
Earnings per share at Enseval Putra Megatrading Tbk are 306.00 IDR (price ÷ EPS = P/E 7.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Enseval Putra Megatrading Tbk (EPMT)?
The dividend yield of Enseval Putra Megatrading Tbk is 7.3% (payout 56.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Enseval Putra Megatrading Tbk (EPMT)?
The net margin of Enseval Putra Megatrading Tbk is 2.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Enseval Putra Megatrading Tbk (EPMT)?
The return on equity (ROE) of Enseval Putra Megatrading Tbk is 10.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Enseval Putra Megatrading Tbk (EPMT)?
On an EBIT basis the return on assets of Enseval Putra Megatrading Tbk is 9.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Enseval Putra Megatrading Tbk (EPMT)?
The operating margin of Enseval Putra Megatrading Tbk is 2.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Enseval Putra Megatrading Tbk (EPMT)?
Revenue at Enseval Putra Megatrading Tbk is growing +18.9% versus a year earlier (3y avg +5.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Enseval Putra Megatrading Tbk (EPMT)?
Earnings per share at Enseval Putra Megatrading Tbk are growing +48.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Enseval Putra Megatrading Tbk (EPMT) hold?
Enseval Putra Megatrading Tbk holds more cash than debt, 522B IDR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Enseval Putra Megatrading Tbk in the live analysis
One click puts Enseval Putra Megatrading Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026